SREBF1 and hypertriglyceridemia: Additionally, SREBP-1c-mediated elevation of apolipoprotein C III also contributes to hypertriglyceridemia through inhibition of lipoprotein lipase, making the degradation of circulatory triglyceride-rich lipoproteins (TrLs) slow down, thus preventing their hepatic clearance [29,41].